Literature DB >> 28345952

The Timing of Early Antibiotics and Hospital Mortality in Sepsis.

Vincent X Liu1, Vikram Fielding-Singh2, John D Greene1, Jennifer M Baker1, Theodore J Iwashyna3,4, Jay Bhattacharya5, Gabriel J Escobar1.   

Abstract

RATIONALE: Prior sepsis studies evaluating antibiotic timing have shown mixed results.
OBJECTIVES: To evaluate the association between antibiotic timing and mortality among patients with sepsis receiving antibiotics within 6 hours of emergency department registration.
METHODS: Retrospective study of 35,000 randomly selected inpatients with sepsis treated at 21 emergency departments between 2010 and 2013 in Northern California. The primary exposure was antibiotics given within 6 hours of emergency department registration. The primary outcome was adjusted in-hospital mortality. We used detailed physiologic data to quantify severity of illness within 1 hour of registration and logistic regression to estimate the odds of hospital mortality based on antibiotic timing and patient factors.
MEASUREMENTS AND MAIN RESULTS: The median time to antibiotic administration was 2.1 hours (interquartile range, 1.4-3.1 h). The adjusted odds ratio for hospital mortality based on each hour of delay in antibiotics after registration was 1.09 (95% confidence interval [CI], 1.05-1.13) for each elapsed hour between registration and antibiotic administration. The increase in absolute mortality associated with an hour's delay in antibiotic administration was 0.3% (95% CI, 0.01-0.6%; P = 0.04) for sepsis, 0.4% (95% CI, 0.1-0.8%; P = 0.02) for severe sepsis, and 1.8% (95% CI, 0.8-3.0%; P = 0.001) for shock.
CONCLUSIONS: In a large, contemporary, and multicenter sample of patients with sepsis in the emergency department, hourly delays in antibiotic administration were associated with increased odds of hospital mortality even among patients who received antibiotics within 6 hours. The odds increased within each sepsis severity strata, and the increased odds of mortality were greatest in septic shock.

Entities:  

Keywords:  antibacterial agents; sepsis; septic shock

Mesh:

Substances:

Year:  2017        PMID: 28345952      PMCID: PMC5649973          DOI: 10.1164/rccm.201609-1848OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  44 in total

1.  Prognostic value of timing of antibiotic administration in patients with septic shock treated with early quantitative resuscitation.

Authors:  Seung Mok Ryoo; Won Young Kim; Chang Hwan Sohn; Dong Woo Seo; Jae Woong Koh; Bum Jin Oh; Kyoung Soo Lim
Journal:  Am J Med Sci       Date:  2015-04       Impact factor: 2.378

Review 2.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

3.  Multicenter Implementation of a Treatment Bundle for Patients with Sepsis and Intermediate Lactate Values.

Authors:  Vincent X Liu; John W Morehouse; Gregory P Marelich; Jay Soule; Thomas Russell; Melinda Skeath; Carmen Adams; Gabriel J Escobar; Alan Whippy
Journal:  Am J Respir Crit Care Med       Date:  2016-06-01       Impact factor: 21.405

4.  Quality of care, process, and outcomes in elderly patients with pneumonia.

Authors:  T P Meehan; M J Fine; H M Krumholz; J D Scinto; D H Galusha; J T Mockalis; G F Weber; M K Petrillo; P M Houck; J M Fine
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

5.  Risk-adjusting hospital inpatient mortality using automated inpatient, outpatient, and laboratory databases.

Authors:  Gabriel J Escobar; John D Greene; Peter Scheirer; Marla N Gardner; David Draper; Patricia Kipnis
Journal:  Med Care       Date:  2008-03       Impact factor: 2.983

6.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.

Authors:  Manuel Iregui; Suzanne Ward; Glenda Sherman; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

7.  Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department.

Authors:  David F Gaieski; Mark E Mikkelsen; Roger A Band; Jesse M Pines; Richard Massone; Frances F Furia; Frances S Shofer; Munish Goyal
Journal:  Crit Care Med       Date:  2010-04       Impact factor: 7.598

8.  Risk-adjusting hospital mortality using a comprehensive electronic record in an integrated health care delivery system.

Authors:  Gabriel J Escobar; Marla N Gardner; John D Greene; David Draper; Patricia Kipnis
Journal:  Med Care       Date:  2013-05       Impact factor: 2.983

9.  Timing and appropriateness of initial antibiotic therapy in newly presenting septic patients.

Authors:  Antonia L Vilella; Charles F Seifert
Journal:  Am J Emerg Med       Date:  2013-10-17       Impact factor: 2.469

Review 10.  A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators.

Authors:  D C Angus; A E Barnato; D Bell; R Bellomo; C-R Chong; T J Coats; A Davies; A Delaney; D A Harrison; A Holdgate; B Howe; D T Huang; T Iwashyna; J A Kellum; S L Peake; F Pike; M C Reade; K M Rowan; M Singer; S A R Webb; L A Weissfeld; D M Yealy; J D Young
Journal:  Intensive Care Med       Date:  2015-05-08       Impact factor: 17.440

View more
  176 in total

1.  Healthcare Utilization and Infection in the Week Prior to Sepsis Hospitalization.

Authors:  Vincent X Liu; Gabriel J Escobar; Rakesh Chaudhary; Hallie C Prescott
Journal:  Crit Care Med       Date:  2018-04       Impact factor: 7.598

2.  Is it time to implement door-to-needle time for "infection attacks"?

Authors:  Kevin B Laupland; Ricard Ferrer
Journal:  Intensive Care Med       Date:  2017-05-02       Impact factor: 17.440

3.  Focus on sepsis: new concepts and findings in sepsis care.

Authors:  Jean-Francois Timsit; Etienne Ruppe; Ricard Ferrer
Journal:  Intensive Care Med       Date:  2018-10-10       Impact factor: 17.440

4.  Sepsis Therapies: Insights from Population Health to Cellular Therapies and Genomic Medicine.

Authors:  Emanuele Rezoagli; Bairbre McNicholas; Peter Moran; John G Laffey
Journal:  Am J Respir Crit Care Med       Date:  2018-12-15       Impact factor: 21.405

5.  National Performance on the Medicare SEP-1 Sepsis Quality Measure.

Authors:  Ian J Barbash; Billie Davis; Jeremy M Kahn
Journal:  Crit Care Med       Date:  2019-08       Impact factor: 7.598

Review 6.  Driving blind: instituting SEP-1 without high quality outcomes data.

Authors:  Jeffrey Wang; Jeffrey R Strich; Willard N Applefeld; Junfeng Sun; Xizhong Cui; Charles Natanson; Peter Q Eichacker
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

7.  Why Antibiotic Treatment Is Not Enough for Sepsis Resolution: an Evaluation in an Experimental Animal Model.

Authors:  Jonathan L Halbach; Andrew W Wang; Dennis Hawisher; David M Cauvi; Radhames E Lizardo; Joseph Rosas; Tony Reyes; Omar Escobedo; Stephen W Bickler; Raul Coimbra; Antonio De Maio
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

8.  Late Vasopressor Administration in Patients in the ICU: A Retrospective Cohort Study.

Authors:  Elizabeth M Viglianti; Sean M Bagshaw; Rinaldo Bellomo; Joanne McPeake; Daniel J Molling; Xiao Qing Wang; Sarah Seelye; Theodore J Iwashyna
Journal:  Chest       Date:  2020-04-09       Impact factor: 9.410

9.  Infectious Diseases Society of America (IDSA) POSITION STATEMENT: Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines.

Authors: 
Journal:  Clin Infect Dis       Date:  2018-05-02       Impact factor: 9.079

10.  Sepsis reconsidered: Identifying novel metrics for behavioral landscape characterization with a high-performance computing implementation of an agent-based model.

Authors:  Chase Cockrell; Gary An
Journal:  J Theor Biol       Date:  2017-07-18       Impact factor: 2.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.